TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Five Below, Splunk, Snap: 'Mad Money' Lightning Round
JIM CRAMER

Five Below, Splunk, Snap: 'Mad Money' Lightning Round

Your Retirement Plans and the Elections: Gridlock, Taxes, Social Security
JIM CRAMER

The One-and-Wait Plan: Cramer's 'Mad Money' Recap

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)
JIM CRAMER

Five Rules For This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: Acceleron, Clovis, Coherus

Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Movers: Coherus, XBiotech, Flexion

AbbVie Stock Lower on Humira Patent Ruling
STOCKS

AbbVie Stock Lower on Humira Patent Ruling

Hostess Brands Tops 4Q Expectations
INVESTING

Here's what blackstone bought and sold in the fourth quarter

Avoid the Market Carnage With These 5 Big Stocks
HEALTH

AbbVie stock higher on Humira patent win

Immunotherapy Stocks Power Higher on Celgene-Juno Deal
STOCKS

Momenta, coherus biosciences are both good options in the biosimilar space

AbbVie Falls After Missing Top- and Bottom-Line Estimates
STOCKS

Abbvie's battle royale

10 Highest-Paying Jobs in 2016 If All You Care About Is Money
STOCKS

16 Biopharma Companies Besides Medivation That Are Attractive Targets

Insider Trading Alert - DUK, STFC And RGLS Traded By Insiders
MARKETS

Coherus BioSciences (CHRS) Is Weak On High Volume Today

New Lifetime High Reached By WGL Holdings (WGL)
MARKETS

Coherus BioSciences (CHRS) Highlighted As Weak On High Volume

Pacira Pharmaceuticals (PCRX) Stock Price Target Cut at Jefferies
MERGERS AND ACQUISITIONS

Put Impax, Akorn and Sagent on Your Watch List of Generics Targets

Immunogen Tanks After Ovarian Cancer Drug Study Fails to Meet Endpoint
MERGERS AND ACQUISITIONS

How Novartis Drug Approval Makes Biosimilar Makers Ripe for Acquisition

Germany's Merck Lifts Full-Year Guidance After Sigma-Aldrich Boosts Sales
OPINION

How to Invest in the New Industry of 'Biosimilar' or 'Generic' Biological Drugs

5 Things You Should Have Bought In 2013
PERSONAL FINANCE

5 Once-Great Retailers That Are Now Halloween Pop-Up Shops

Sotheby's Weighs Sale of New York Headquarters
OPINION

Dan Loeb's Doomed Sotheby's Campaign

The Deal: Men's Wearhouse Fires Founder in Course of Review
MERGERS AND ACQUISITIONS

The Deal: Men's Wearhouse Fires Founder in Course of Review

Stocks Inch Higher as Yellen Eases Markets Into Drop in 'Patient' Phrasing
STOCKS

10 Once-Great Retailers That Are Now Pop-Up Halloween Shops

Perilous Reversal Watch: Yamana Gold (AUY)
MARKETS

Charming Shoppes Stock Hits New 52-Week High (CHRS)

Jim Cramer's 'Mad Money' Recap: American Consumers Are Still Afraid
JIM CRAMER

Cramer's 'Mad Money' Recap: America Between Rock, Hard Place

European Stocks Sink as Greek Crisis Imminent; Automakers Fall
MARKETS

Market Preview: Feel the Fear

Don't Panic! Despite First-Quarter Fears, U.S. Economic Expansion Won't End Soon
STOCKS

Stocks to Watch: Facebook, RIM (Update 1)

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: SBW, HIO, ETG
MARKETS

Charming Shoppes Reaches New 52-Week High (CHRS)